Letter: Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromesShow others and affiliations
2018 (English)In: Blood, ISSN 0006-4971, E-ISSN 1528-0020, Vol. 132, no 21, p. 2309-2313Article in journal, Letter (Other academic) Published
Abstract [en]
n/a
Place, publisher, year, edition, pages
Washington, DC, United States: American Society of Hematology , 2018. Vol. 132, no 21, p. 2309-2313
National Category
Hematology
Identifiers
URN: urn:nbn:se:liu:diva-153373DOI: 10.1182/blood-2017-05-787390ISI: 000450906400017PubMedID: 30322869Scopus ID: 2-s2.0-85057096061OAI: oai:DiVA.org:liu-153373DiVA, id: diva2:1271820
Note
Funding Agencies|National Heart, Lung, and Blood Institute, National Institutes of Health [R01HL-118281, R01HL123904, R01HL128425, R01HL132071]; Aplastic Anemia (AA) and Myelodysplastic Syndromes (MDS) Foundation; Edward P. Evans Foundation; Cancerfonden and Barncancerfonden; Instituto de Salud Carlos III, Ministerio de Economia y Competividad, Spain [PI/14/00013]; Generalitat de Catalunya by Jose Carreras Leukamie-Stiftung [AR 14/34, 2014 SGR225]; Centres de Recerca de Catalunya Programme/Generalitat de
2018-12-182018-12-182019-01-08Bibliographically approved